Mumbai: Citing precautions and contraindications for the COVID-19 vaccine, the government said interchangeability of vaccine isn’t allowed while women who’re pregnant shouldn’t receive the COVID-19 vaccine at this time.
Contraindications also include people with a history of an allergic reaction to the previous dose of COVID-19 vaccine. If required, the COVID-19 vaccine and other vaccines should be separated by at least 14 days
In a letter to all states and union territories, the ministry said that coronavirus vaccination is indicated for only 18 years and above under the Emergency Use Authority. If necessary, the COVID-19 vaccine and other vaccines should be isolated with an interval of at least 14 days.
Manohar Agnani, Additional Secretary of the Union Ministry of Health, said in the letter, “The exchangeability of COVID-19 vaccines is not allowed. The second dose should also be of the same COVID-19 vaccine as the first dose.”
The Ministry listed the precautions and contraindications for COVID-19 vaccination with a comparative factsheet for both vaccines (covishield and covaxin), including vaccination platforms, physical specifications, dosage, cold-chain storage requirements, contraindications, and minor AEFI (adverse). Have done about. Vaccination after the event).
It stated that this information should be disseminated to program managers at all levels and to cold-chain handlers and vaccinators for reference prepared by them.
The Ministry of Health warned against the administration of previous doses of the COVID-19 vaccine and in those with immediate or delayed onset anaphylaxis or allergic reaction to vaccines or injectable therapies, pharmaceutical products, food items, among others.
According to the letter, in the case of individuals with active symptoms of SARS-CoV-2 infection, coronavirus-infected patients who receive anti-SARS-CoV-2 monoclonal antibodies or convulsive plasma and acutely unwell and hospitalized patients due to any disease COVID-19 vaccination has to be postponed four to eight weeks after recovery.
“Pregnant and lactating women have not been part of any COVID-19 vaccine clinical trial so far. Therefore, women who are pregnant and not sure about their pregnancy and lactating women are currently COVID-19 Going through the vaccine,” the letter added.
This vaccine should be administered with caution in individuals with a history of any bleeding or coagulation disorder (eg clotting deficiency, coagulopathy, or platelet disorder).
“Past history of SARV-CoV-2 infection and or RT-PCR positive disease, history of chronic diseases and illnesses and history of chronic diseases and morbidities and immuno-deficiency, HIV, patients on immune suppression due to any condition,” the letter stated.
The letter also mentions mild AEFI after vaccination of both vaccines.
In the case of covishied, some mild AEFI can occur like injection site tenderness, injection site pain, headache, fatigue, myalgia, malaise, pyrexia, chills and arthritis, and nausea.
Some mild AEFI in case of covaxin includes injection site pain, headache, fatigue, fever, body aches, abdominal pain, nausea and vomiting, dizziness-dizzy spells, tremors, sweating, cold, cough, and swelling of the injection.
Paracetamol may be used to provide symptomatic relief from post-vaccination adverse reactions, the letter added.